AgomAb Therapeutics NV (AGMB) News
NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
9.08-0.14 (-1.52%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AGMB news summary
We found 1 recent headline mentioning AgomAb Therapeutics NV (AGMB): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, AGMB is down 1.52% at $9.08. The most recent story, "Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology